270 related articles for article (PubMed ID: 26078037)
1. Structure-based design of diverse inhibitors of Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase: combined molecular docking, dynamic simulation, and biological activity.
Soni V; Suryadevara P; Sriram D; ; Kumar S; Nandicoori VK; Yogeeswari P
J Mol Model; 2015 Jul; 21(7):174. PubMed ID: 26078037
[TBL] [Abstract][Full Text] [Related]
2. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
[TBL] [Abstract][Full Text] [Related]
3. Inhibition studies on Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase (GlmU).
Tran AT; Wen D; West NP; Baker EN; Britton WJ; Payne RJ
Org Biomol Chem; 2013 Dec; 11(46):8113-26. PubMed ID: 24158720
[TBL] [Abstract][Full Text] [Related]
4. PknB-mediated phosphorylation of a novel substrate, N-acetylglucosamine-1-phosphate uridyltransferase, modulates its acetyltransferase activity.
Parikh A; Verma SK; Khan S; Prakash B; Nandicoori VK
J Mol Biol; 2009 Feb; 386(2):451-64. PubMed ID: 19121323
[TBL] [Abstract][Full Text] [Related]
5. Characterization of substrate binding and catalysis in the potential antibacterial target N-acetylglucosamine-1-phosphate uridyltransferase (GlmU).
Mochalkin I; Lightle S; Zhu Y; Ohren JF; Spessard C; Chirgadze NY; Banotai C; Melnick M; McDowell L
Protein Sci; 2007 Dec; 16(12):2657-66. PubMed ID: 18029420
[TBL] [Abstract][Full Text] [Related]
6. Crystal structures of Streptococcus pneumoniae N-acetylglucosamine-1-phosphate uridyltransferase, GlmU, in apo form at 2.33 A resolution and in complex with UDP-N-acetylglucosamine and Mg(2+) at 1.96 A resolution.
Kostrewa D; D'Arcy A; Takacs B; Kamber M
J Mol Biol; 2001 Jan; 305(2):279-89. PubMed ID: 11124906
[TBL] [Abstract][Full Text] [Related]
7. Expression, essentiality, and a microtiter plate assay for mycobacterial GlmU, the bifunctional glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase.
Zhang W; Jones VC; Scherman MS; Mahapatra S; Crick D; Bhamidi S; Xin Y; McNeil MR; Ma Y
Int J Biochem Cell Biol; 2008; 40(11):2560-71. PubMed ID: 18573680
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations.
Saxena S; Abdullah M; Sriram D; Guruprasad L
J Biomol Struct Dyn; 2018 Sep; 36(12):3184-3198. PubMed ID: 28948866
[TBL] [Abstract][Full Text] [Related]
9. Computationally Guided Identification of Novel Mycobacterium tuberculosis GlmU Inhibitory Leads, Their Optimization, and in Vitro Validation.
Mehra R; Rani C; Mahajan P; Vishwakarma RA; Khan IA; Nargotra A
ACS Comb Sci; 2016 Feb; 18(2):100-16. PubMed ID: 26812086
[TBL] [Abstract][Full Text] [Related]
10. Identification of Mtb GlmU Uridyltransferase Domain Inhibitors by Ligand-Based and Structure-Based Drug Design Approaches.
Singh M; Kempanna P; Bharatham K
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566155
[TBL] [Abstract][Full Text] [Related]
11. Novel lead compound optimization and synthesized based on the target structure of Xanthomonas oryzae pv. oryzae GlmU.
Qi X; Deng W; Gao M; Mao B; Xu S; Chen C; Zhang Q
Pestic Biochem Physiol; 2015 Jul; 122():22-8. PubMed ID: 26071803
[TBL] [Abstract][Full Text] [Related]
12. Structure and function of GlmU from Mycobacterium tuberculosis.
Zhang Z; Bulloch EM; Bunker RD; Baker EN; Squire CJ
Acta Crystallogr D Biol Crystallogr; 2009 Mar; 65(Pt 3):275-83. PubMed ID: 19237750
[TBL] [Abstract][Full Text] [Related]
13. An aminoquinazoline inhibitor of the essential bacterial cell wall synthetic enzyme GlmU has a unique non-protein-kinase-like binding mode.
Larsen NA; Nash TJ; Morningstar M; Shapiro AB; Joubran C; Blackett CJ; Patten AD; Boriack-Sjodin PA; Doig P
Biochem J; 2012 Sep; 446(3):405-13. PubMed ID: 22721802
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of novel small molecule inhibitors of the acetyltransferase activity of Escherichia coli N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU).
Sharma R; Rani C; Mehra R; Nargotra A; Chib R; Rajput VS; Kumar S; Singh S; Sharma PR; Khan IA
Appl Microbiol Biotechnol; 2016 Apr; 100(7):3071-85. PubMed ID: 26563552
[TBL] [Abstract][Full Text] [Related]
15. Kinetic properties of Mycobacterium tuberculosis bifunctional GlmU.
Zhou Y; Xin Y; Sha S; Ma Y
Arch Microbiol; 2011 Oct; 193(10):751-7. PubMed ID: 21594607
[TBL] [Abstract][Full Text] [Related]
16. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
Kumar R; Garg P; Bharatam PV
J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
[TBL] [Abstract][Full Text] [Related]
17. Design and Synthesis of Various 5'-Deoxy-5'-(4-Substituted-1,2,3-Triazol-1-yl)-Uridine Analogues as Inhibitors of
Hervin V; Arora R; Rani J; Ramchandran S; Bajpai U; Agrofoglio LA; Roy V
Molecules; 2020 Oct; 25(21):. PubMed ID: 33114668
[TBL] [Abstract][Full Text] [Related]
18. Structure of a small-molecule inhibitor complexed with GlmU from Haemophilus influenzae reveals an allosteric binding site.
Mochalkin I; Lightle S; Narasimhan L; Bornemeier D; Melnick M; Vanderroest S; McDowell L
Protein Sci; 2008 Mar; 17(3):577-82. PubMed ID: 18218712
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of UDP-N-acetylglucosamine-enolpyruvate reductase (MurB) from Mycobacterium tuberculosis.
Eniyan K; Dharavath S; Vijayan R; Bajpai U; Gourinath S
Biochim Biophys Acta Proteins Proteom; 2018 Mar; 1866(3):397-406. PubMed ID: 29203374
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 1: Hit to lead evaluation of a novel arylsulfonamide series.
Green OM; McKenzie AR; Shapiro AB; Otterbein L; Ni H; Patten A; Stokes S; Albert R; Kawatkar S; Breed J
Bioorg Med Chem Lett; 2012 Feb; 22(4):1510-9. PubMed ID: 22297115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
